
A new SARS-Coronavirus protein inhibitor is a promising pan-coronavirus drug candidate
Srijita Banerjee
To combat the COVID-19 pandemic and potential future outbreaks, a collaborative study from Shiv Nadar Institute of Eminence (SNIoE), Noida, and other research institutes discovered a chemical compound called STL522228. This promising compound inhibits a crucial protein in the Severe Acute Respiratory Syndrome (SARS) coronavirus, shedding light on the pressing need for effective antiviral treatments.